Single Intravitreal Aflibercept Injection for Unilateral Acute Nonarteritic Ischemic Optic Neuropathy


Creative Commons License

AYHAN Z., Kocaoglu G., YAMAN A., SÖYLEV BAJIN M. F., SAATCİ A. O.

CASE REPORTS IN OPHTHALMOLOGICAL MEDICINE, cilt.2015, 2015 (ESCI) identifier identifier

Özet

Acute nonarteritic ischemic optic neuropathy (ANAION) is the most common optic neuropathy in the elderly population without a well-established treatment. A 67-year-oldman with a sudden painless visual loss in his left eye of one-day duration was diagnosed to have left ANAION. Next day, 2mg aflibercept injection was injected intravitreally in OS. Visual acuity improved to 7/10 from 1/10 a week after the injection. Mean retinal nerve fiber layer thickness (RNFLT) was reduced to 159,7 mu m from 182,4 mu m at the first week. Visual fields improved dramatically during the follow-up of three months. The aim of this study is to present a case having ANAION treated with a single intravitreal aflibercept injection and discuss the place of intravitreal anti-VEGF injections in the treatment of armamentarium of ANAION.